Ascendis Pharma
ASND
$135.90
Share price
-0.75%
Change (1 day)
77.79%
Change (1 year)
Categories
Ascendis Pharma (ASND) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $1.07 B
According to Ascendis Pharma 's latest financial reports the company's total liabilities are $1.07 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Ascendis Pharma - Total liabilities on balance sheet (from 2013 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $1.07 B | 21.33% |
| 2022-12-31 | $0.88 B | 288.25% |
| 2021-12-31 | $0.22 B | 31.37% |
| 2020-12-31 | $0.17 B | 94.56% |
| 2019-12-31 | $89.19 M | 100.33% |
| 2018-12-31 | $44.52 M | 56.03% |
| 2017-12-31 | $28.53 M | 101.4% |
| 2016-12-31 | $14.16 M | 13.21% |
| 2015-12-31 | $12.51 M | -20% |
| 2014-12-31 | $15.64 M | -44.48% |
| 2013-12-31 | $28.17 M | -10.7% |
| 2012-12-31 | $31.54 M | 7.78% |
| 2011-12-31 | $29.27 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Akebia Therapeutics AKBA | $0.27 B | -74.64% | 🇺🇸 USA |
 Affimed
AFMD | $46.53 M | -95.67% | 🇩🇪 Germany |
 Advaxis ADXS | $13.22 M | -98.77% | 🇺🇸 USA |